
Quotient Limited QTNT
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Quotient Limited Abschreibung & Amortisation 2011-2026 | QTNT
Abschreibung & Amortisation Jährlich Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 8.8 M | 12.5 M | 12.7 M | 10.3 M | 9.38 M | 2.86 M | 1.18 M | 519 K | 337 K | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 12.7 M | 337 K | 6.5 M |
Abschreibung & Amortisation Vierteljährlich Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 2.34 M | 6.43 M | 4.09 M | - | 2.9 M | 9 M | 6.07 M | 3.01 M | 3.06 M | 9.5 M | 6.42 M | - | 2.58 M | 2.59 M | 2.46 M | - | 2.37 M | 7.03 M | 4.64 M | - | 643 K | 1.57 M | 907 K | - | 316 K | 938 K | 282 K | - | - | 376 K | 240 K | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 9.5 M | 240 K | 3.32 M |
Abschreibung & Amortisation anderer Aktien in der Diagnostik & Forschung
| Name | Abschreibung & Amortisation | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M | ||
|
Sotera Health Company
SHC
|
94.9 M | $ 13.28 | -1.96 % | $ 3.77 B | ||
|
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | ||
|
Biodesix
BDSX
|
5.77 M | $ 14.59 | -0.07 % | $ 1.89 B | ||
|
Agilent Technologies
A
|
321 M | $ 110.88 | -2.29 % | $ 33.7 B | ||
|
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | ||
|
BioNano Genomics
BNGO
|
9.53 M | $ 1.15 | - | $ 6.26 M | ||
|
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 16.57 | -10.43 % | $ 178 M | ||
|
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
264 K | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
252 M | $ 62.48 | -5.47 % | $ 24.4 B | ||
|
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | ||
|
Co-Diagnostics
CODX
|
1.23 M | $ 4.4 | 101.83 % | $ 129 M | ||
|
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | ||
|
Fulgent Genetics
FLGT
|
24.9 M | $ 15.62 | -4.64 % | $ 472 M | ||
|
Guardant Health
GH
|
39.7 M | $ 85.04 | -3.47 % | $ 10.7 B | ||
|
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | ||
|
Castle Biosciences
CSTL
|
16 M | $ 24.15 | -2.23 % | $ 671 M | ||
|
Charles River Laboratories International
CRL
|
403 M | $ 158.32 | -4.12 % | $ 7.85 B | ||
|
Quest Diagnostics Incorporated
DGX
|
570 M | $ 196.15 | -1.01 % | $ 21.8 B | ||
|
Organovo Holdings
ONVO
|
266 K | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
175 K | - | -16.95 % | $ 1.54 M | ||
|
ICON Public Limited Company
ICLR
|
488 M | $ 101.83 | -1.21 % | $ 8.4 B | ||
|
DarioHealth Corp.
DRIO
|
307 K | $ 8.45 | - | $ 33.7 M | ||
|
Illumina
ILMN
|
354 M | $ 117.51 | -5.54 % | $ 18.7 B | ||
|
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | ||
|
PerkinElmer
PKI
|
405 M | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
142 M | - | - | $ 21.2 M | ||
|
Interpace Biosciences
IDXG
|
300 K | $ 1.68 | -2.89 % | $ 7.37 M | ||
|
IQVIA Holdings
IQV
|
1.14 B | $ 164.58 | -2.85 % | $ 28.3 B | ||
|
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
203 M | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
119 M | $ 8.84 | -3.39 % | $ 1.92 B | ||
|
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | ||
|
Personalis
PSNL
|
10.9 M | $ 6.4 | -12.64 % | $ 379 M | ||
|
Laboratory Corporation of America Holdings
LH
|
681 M | $ 266.29 | -0.78 % | $ 22.2 B | ||
|
Senseonics Holdings
SENS
|
1.51 M | $ 6.54 | -0.3 % | $ 273 M | ||
|
Psychemedics Corporation
PMD
|
1.7 M | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
1.22 M | $ 26.03 | -1.92 % | $ 33.8 M | ||
|
CareDx, Inc
CDNA
|
15 M | $ 16.83 | -3.66 % | $ 897 M | ||
|
Syneos Health
SYNH
|
236 M | - | - | $ 4.46 B |